Volume-Enhancing HA Fillers

Product Introduction:

Hyaluronic acid-based dermal fillers, such as HA Dermal Filler, are designed to correct facial imperfections while delivering deep hydration and volume restoration. HA is a polysaccharide naturally found in the human body that exhibits excellent compatibility with tissues and outstanding moisture-binding capacity. Once injected, it attracts and retains water molecules, forming a gel that fills wrinkles, contours facial features, and revitalizes the skin’s texture. The use of cross-linking agents, including BDDE, creates a stable three-dimensional network within the filler, enhancing its durability and ensuring a controlled, even breakdown in the tissue over a period ranging from six months to a year and a half.

Instructions for Use

Prior to any filler treatment, practitioners must confirm that the product is undamaged and check both its lot number and expiration date. The skin should be carefully cleansed and disinfected to prevent contamination. For patient comfort, topical anesthetics can be applied or lidocaine-containing fillers can be chosen. During treatment, the correct injection instrument, whether a fine needle or blunt cannula, should be selected according to the target area and tissue depth. Injections may be placed at intradermal, subdermal, or supraperiosteal layers using techniques such as linear threading, serial puncture, fanning, or cross-hatching. Administering the filler slowly and evenly is key, ensuring that it does not enter blood vessels. Post-procedure care may include gentle massage to shape the area, application of cold compresses to reduce swelling or redness, and avoiding excessive heat, vigorous exercise, and alcohol for at least three days. Any prolonged swelling, nodules, or discomfort should be promptly assessed by a healthcare professional.

Precautions and Contraindications

The use of HA fillers is contraindicated in pregnant or lactating patients, as well as in areas of active infection, inflammation, or skin prone to keloids. Individuals with known allergies to hyaluronic acid or lidocaine should avoid treatment due to the risk of hypersensitivity reactions. Those with autoimmune diseases or bleeding disorders may be at higher risk for complications and should consult a specialist prior to treatment. In all cases, injections should be performed only by qualified medical professionals under sterile conditions. Care must be taken to avoid intravascular injection, as this can result in vascular blockage. Treatments in the same area should not be repeated too frequently; several months should pass between sessions to ensure safe tissue recovery. In the event of vascular compromise—indicated by intense pain, pallor, or a mottled skin pattern—hyaluronidase must be injected immediately to prevent tissue damage.

Storage and Transportation